BioFinance with Gowling Lafleur Henderson Apr.6-8

Bio Finance with Gowling Lafleur Henderson Apr.6-8

This week’s BioFinance 2010 conference in Toronto brings light to a sector that has experienced significant challenges in 2009. With the biotechnology outlook dim, many companies were the targets of mergers and acquisitions. Part of the sector’s performance in 2009 can also be attributed to uncertainty about health care reform legislation in the United States. Given recent developments and the likelihood of a shake up within the sector, will biotechnology and medical technology be in demand for Canadian investors?

This week’s BioFinance 2010 conference in Toronto brings light to a sector that has experienced significant challenges in 2009. With the biotechnology outlook dim, many companies were the targets of mergers and acquisitions. Part of the sector’s performance in 2009 can also be attributed to uncertainty about health care reform legislation in the United States. Given recent developments and the likelihood of a shake up within the sector, will biotechnology and medical technology be in demand for Canadian investors?

Investors, analysts and legal professionals are looking towards next week’s conference for guidance on how this sector fairs for the remainder of 2010 and beyond. This industry may be positioned for renewed investor interest in 2010, despite the market lagging in 2009.

Gowling Lafleur Henderson (Gowlings) was recently named one of the world’s life science patent litigation law firms. I would be happy to set up an opportunity for you to speak with Michael Herman and Bob Ford, partners in Gowlings’ business law department, who are available during and after this conference to discuss how Canadians should view the biotechnology industry in 2010 and how they see the next generation of medicine development in Canada. Both professionals work to service the particular needs of technology and life sciences companies and those investors that fund them. Please let me know if you would like to discuss this opportunity.

James Dean

James Dean - President ~ Money Canada Limited (MONEY.CA)

Comments are closed.